6 GOVERNANCE 221 CORPORATE GOVERNANCE OVERVIEW STATEMENT This Corporate Governance Overview Statement (“Statement”) is prepared in compliance with the Main Market Listing Requirements of Bursa Malaysia Securities Berhad and should be read together with the Corporate Governance Report (“CG Report”), which sets out in detail the Company’s application of each Practice under the Malaysian Code on Corporate Governance 2021 (“MCCG”). This Statement presents a summary of the Company’s corporate governance framework and practices, with emphasis on the Board’s key activities and time commitment throughout the financial year 2025. During the year, UEM Edgenta was honoured with the Overall Excellence Award 2025 and ranked 38th among the Top 50 Public Listed Companies at the National Corporate Governance & Sustainability Awards (NACGSA) 2025, reflecting the Company’s continued commitment to strong governance and sustainability practices. The Board of Directors (“Board”) recognises that sound corporate governance, effective stewardship, and the instillation of strong corporate values are critical to the Company’s long-term success. Accordingly, the Board remains steadfast in upholding and strengthening the principles of good governance, ensuring that these principles are deeply embedded across the organisation and consistently demonstrated in the Company’s conduct and decision-making. The Company is led by an effective Board, collectively responsible for its long-term success, ensuring its efficient operation, and remaining committed to maintaining strong momentum in pursuit of excellence in governance. The preparation of this Statement was guided by the following three (3) key principles: BOARD LEADERSHIP AND EFFECTIVENESS A BOARD LEADERSHIP AND EFFECTIVENESS A EFFECTIVE AUDIT AND RISK MANAGEMENT B INTEGRITY IN CORPORATE REPORTING AND MEANINGFUL RELATIONSHIP WITH STAKEHOLDERS C BOARD RESPONSIBILITIES GOVERNANCE FRAMEWORK The Board is committed to discharge its responsibilities and obligations to shareholders and all other stakeholders. In carrying out its duties, the Board adheres to the Board Charter and the Discretionary Authority Limits, which collectively outline the roles and responsibilities of the Board as well as the matters delegated to the Board Committees, the Managing Director/Chief Executive Officer, and Management. This framework underpins the Board’s commitment to integrity in corporate reporting and to foster meaningful relationships with stakeholders. The Board Charter, which is available on the Company’s website at www.uemedgenta.com, provides clear guidance to ensure effective leadership. It sets out the Board’s oversight responsibilities in relation to management performance, internal controls, risk management, governance practices, policies and the overall viability and sustainability of the Group. The Board’s main roles and responsibilities among others are as follows: • Establishing, reviewing and adopting the strategic plans and direction for the Group. • Overseeing the conduct of the Group’s business to evaluate whether the business is being properly managed. • Identifying principal risks and ensuring the implementation of appropriate systems to manage these risks. • Succession planning, including appointing, training, fixing the compensation of and where appropriate, replacing senior management. • Developing and implementing an investor relations programme or Corporate Disclosure Policy for the Group. • Reviewing the adequacy and the integrity of the Group’s internal control systems and management information systems, including system for compliance with applicable laws, regulations, rules, directives and guidelines. The CG Report is available on the Company’s website at www.uemedgenta.com.
RkJQdWJsaXNoZXIy NDgzMzc=